| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 365 | 378 | 409 | 400 | 432 | 455 | 492 | 459 | 489 | 526 | 565 | 558 | 653 | 655 | 714 | 735 | 776 | 782 | 829 | 791 | 750 | 398 | 611 | 755 | 846 | 867 | 952 | 967 | 951 | 1,041 | 1,173 | 1,140 | 1,236 | 1,249 | 1,324 | 1,222 | 1,273 | 1,331 | 1,390 | 1,353 | 1,503 | 1,532 | 1,668 |
| Expenses | 326 | 344 | 360 | 358 | 392 | 402 | 426 | 406 | 425 | 473 | 502 | 502 | 597 | 607 | 640 | 657 | 676 | 675 | 702 | 684 | 659 | 486 | 575 | 648 | 698 | 728 | 774 | 787 | 768 | 842 | 898 | 874 | 946 | 963 | 997 | 925 | 955 | 1,004 | 1,058 | 1,028 | 1,126 | 1,171 | 1,243 |
| EBITDA | 39 | 34 | 49 | 42 | 40 | 54 | 66 | 53 | 64 | 53 | 63 | 56 | 56 | 49 | 74 | 79 | 101 | 107 | 127 | 107 | 92 | -87 | 36 | 107 | 148 | 139 | 179 | 180 | 182 | 200 | 275 | 266 | 290 | 286 | 327 | 297 | 318 | 327 | 332 | 325 | 377 | 361 | 425 |
| Operating Profit % | 10 % | 8 % | 11 % | 10 % | 8 % | 11 % | 13 % | 11 % | 12 % | 9 % | 10 % | 9 % | 8 % | 7 % | 10 % | 10 % | 12 % | 13 % | 15 % | 13 % | 11 % | -23 % | 4 % | 14 % | 17 % | 15 % | 18 % | 18 % | 18 % | 19 % | 21 % | 23 % | 23 % | 22 % | 24 % | 23 % | 23 % | 23 % | 23 % | 23 % | 24 % | 22 % | 24 % |
| Depreciation | 19 | 18 | 18 | 19 | 21 | 19 | 20 | 20 | 21 | 22 | 29 | 24 | 26 | 33 | 34 | 35 | 36 | 41 | 43 | 46 | 55 | 46 | 46 | 47 | 45 | 45 | 46 | 46 | 47 | 48 | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 61 | 65 | 70 | 83 | 84 | 88 |
| Interest | 12 | 9 | 8 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 8 | 8 | 21 | 17 | 18 | 18 | 18 | 22 | 22 | 21 | 21 | 20 | 19 | 19 | 18 | 17 | 17 | 16 | 16 | 15 | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 |
| Profit Before Tax | 10 | 10 | 26 | 20 | 13 | 29 | 41 | 28 | 37 | 21 | 26 | 24 | 9 | -1 | 22 | 26 | 47 | 43 | 62 | 40 | 16 | -153 | -30 | 42 | 85 | 77 | 116 | 117 | 119 | 137 | 211 | 190 | 214 | 206 | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 |
| Tax | 11 | 11 | 16 | 14 | 8 | 12 | 15 | 11 | 15 | 10 | 10 | 10 | -1 | 3 | 8 | 13 | 10 | 13 | 17 | 9 | 4 | -34 | -26 | 1 | 17 | 1 | 17 | 20 | 50 | 27 | 42 | 36 | 40 | 22 | 22 | 21 | 34 | 30 | 33 | 26 | 57 | 35 | 37 |
| Net Profit | -1 | -1 | 10 | 6 | 5 | 17 | 27 | 17 | 22 | 11 | 17 | 14 | 10 | -4 | 14 | 13 | 37 | 30 | 45 | 31 | 12 | -120 | -3 | 41 | 68 | 76 | 99 | 98 | 69 | 111 | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 259 |
| EPS in ₹ | 0.00 | -0.03 | 0.52 | 0.29 | 0.25 | 0.85 | 1.31 | 0.84 | 1.10 | 0.54 | 0.82 | 0.70 | 0.48 | -0.21 | 0.67 | 0.63 | 1.83 | 1.49 | 2.23 | 1.55 | 0.59 | -5.90 | -0.17 | 2.01 | 3.35 | 3.75 | 4.89 | 4.80 | 3.40 | 5.45 | 8.31 | 7.57 | 8.53 | 9.06 | 11.16 | 9.26 | 9.39 | 9.92 | 9.76 | 9.50 | 9.71 | 9.68 | 12.72 |
Narayana Hrudayalaya
Narayana Hrudayalaya
1,916.90
-20.70
(-1.07%)
Market Cap
₹39,173.90 Cr
PE Ratio
48.80
Volume
2,70,066.00
Day High - Low
₹1,961.00 - ₹1,910.00
52W High-Low
₹2,370.20 - ₹1,256.55
Key Fundamentals
Market Cap
39,173.90 Cr
EPS
38.90
PB Ratio
10.16
Book Value
198.66
EBITDA
1,368.40
Dividend Yield
0.22 %
Industry
Healthcare Services Sector
Hospitals ROE Growth %
-
Debt to Equity
0.62
Analyst Rating and Forecast
- By Refinitiv from9 analysts
Actual
Company News
View All News
Narayana Health Receives GST Penalty of Rs 24.62 Lakh from Karnataka Authority4 days ago
Narayana Health received a GST penalty order of Rs 24.62 lakh from Karnataka's Deputy Commissioner for alleged non-payment of GST amounting to Rs 2.45 crore on revenue exempted from GST being healthcare services for financial year 2021-22. The company states there is no material impact on its financials or operations and plans to file an appeal with the Appellate Authority challenging the order.
Narayana Hrudayalaya Ltd. witnessed a significant block trade worth Rs. 219.85 crores involving 1,121,674 shares at Rs. 1,960 per share on the NSE. The large-volume transaction indicates substantial institutional or bulk investor activity in the healthcare company's stock.
Narayana Health Reports Strong Q2 FY26 Performance with 20% EBITDA Growth and Robust Cayman Operations
Nov 24, 2025
Nov 24, 2025Narayana Health delivered impressive quarterly results with 20% EBITDA growth in India operations despite reduced bed capacity, driven by improved payor-mix optimization and higher-end procedures including 97 robotic cardiac surgeries in September. The company's Cayman Islands operations showed exceptional performance with 70% revenue growth in insurance business and hospital margins of 43-44%, while completing the Practice Plus acquisition in UK for expanding international presence.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,097.40 | #1 1,06,693.20 | 83.67 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 39.18 | |
7,189.50 | 1,03,374.00 | 61.72 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 30.43 | |
888.55 | 67,081.80 | 68.04 | 7,849.70 | 13.25 | 809 | 70.27 | 29.52 | |
1,916.90 | #4 39,173.90 | #1 48.80 | #4 5,575.00 | #10 12.29 | #4 790 | #4 30.03 | 52.81 | |
635.10 | 32,905.90 | 94.45 | 4,286.70 | 15.12 | 337 | 14.65 | 33.20 | |
1,163.50 | 31,273.80 | 58.06 | 3,771.40 | 12.59 | 481 | 21.10 | 32.67 | |
704.00 | 28,169.80 | 75.73 | 3,067.00 | 21.98 | 415 | -40.35 | 54.73 | |
506.00 | 15,997.60 | 107.45 | 1,757.00 | 27.64 | 110 | 71.36 | 47.15 | |
1,350.90 | 13,719.60 | 53.31 | 1,566.90 | 17.46 | 244 | -4.30 | 50.35 | |
720.05 | 10,152.70 | 254.74 | 2,257.70 | 17.03 | 49 | 0.00 | 46.65 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
12.29 %
Net Income Growth
0.48 %
Cash Flow Change
-7.58 %
ROE
-20.08 %
ROCE
-17.99 %
EBITDA Margin (Avg.)
-0.28 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 | 7,265 |
| Fixed Assets | 913 | 1,055 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 |
| Current Assets | 260 | 286 | 302 | 479 | 527 | 586 | 665 | 909 | 1,294 | 1,946 | 2,550 |
| Capital Work in Progress | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 |
| Investments | 0 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 |
| Other Assets | 437 | 401 | 416 | 644 | 725 | 701 | 669 | 951 | 1,315 | 1,615 | 1,829 |
| Total Liabilities | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 | 7,265 |
| Current Liabilities | 343 | 315 | 323 | 510 | 510 | 602 | 703 | 780 | 987 | 1,110 | 1,193 |
| Non Current Liabilities | 258 | 365 | 361 | 989 | 1,045 | 1,153 | 946 | 861 | 1,042 | 1,629 | 2,444 |
| Total Equity | 769 | 876 | 963 | 1,036 | 1,082 | 1,137 | 1,121 | 1,489 | 2,132 | 2,885 | 3,628 |
| Reserve & Surplus | 568 | 674 | 761 | 833 | 878 | 933 | 917 | 1,286 | 1,928 | 2,681 | 3,423 |
| Share Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 8 | -2 | 59 | -4 | 97 | 205 |
| Investing Activities | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 |
| Operating Activities | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 |
| Financing Activities | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 489 | 544 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 11.60 % | 0.00 % | 10.91 % | 10.01 % | 9.68 % | 9.44 % | 9.66 % | 10.46 % | 10.49 % |
| DIIs | 14.80 % | 15.55 % | 16.15 % | 14.61 % | 13.76 % | 13.43 % | 16.18 % | 14.58 % | 14.14 % | 11.95 % | 10.89 % | 9.46 % | 9.51 % | 8.23 % | 7.90 % | 8.69 % | 8.52 % | 8.09 % | 7.76 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 4.64 % | 4.97 % | 4.85 % | 5.11 % | 5.92 % | 6.87 % | 5.86 % | 6.93 % | 7.10 % | 7.99 % | 8.46 % | 9.04 % | 10.00 % | 11.68 % | 12.13 % | 11.58 % | 11.47 % | 11.18 % | 11.45 % |
| Others | 16.71 % | 15.63 % | 15.14 % | 16.43 % | 16.46 % | 15.85 % | 14.11 % | 14.64 % | 14.90 % | 16.20 % | 5.20 % | 17.65 % | 5.73 % | 6.23 % | 6.43 % | 6.43 % | 6.50 % | 6.42 % | 6.45 % |
| No of Share Holders | 0 | 36,360 | 44,526 | 43,565 | 43,807 | 52,747 | 65,173 | 68,130 | 75,370 | 86,631 | 1,02,994 | 1,20,506 | 1,38,052 | 1,60,686 | 1,78,356 | 1,77,792 | 1,85,787 | 2,05,639 | 2,26,480 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 | 1 | 2.5 | 4 | 4.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.4 | 0.25 | 0.00 | 0.13 | 0.19 | 0.24 | 0.23 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Aug 2022 |  Dividend | ₹ 1.00 /share | 22 Aug 2022 | 659.80 | 705.15 |
| 07 Jul 2023 | Dividend | ₹ 2.50 /share | 07 Jul 2023 | 767.85 | 1,012.95 |
| 02 Aug 2024 | Dividend | ₹ 4.00 /share | 02 Aug 2024 | 1,255.10 | 1,252.75 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 1,255.10 | 1,265.50 |
| 31 Oct 2024 |  Quarterly Result Announcement | NA | 31 Oct 2024 | 1,236.20 | 1,222.55 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 1,372.70 | 1,329.00 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 1,790.70 | 1,724.30 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 1,991.45 | 1,916.05 |
| 01 Aug 2025 | Dividend | ₹ 4.50 /share | 01 Aug 2025 | 1,724.30 | 1,916.05 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 1,724.30 | 1,753.75 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 1,819.90 | 1,777.75 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
1 day agoImposition Of GST Penalty4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptNov 24, 2025
Nov 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 19, 2025
Nov 19, 2025Clarification On The Volume Movement Letter Dated November 18 2025 Received From BSE Ltd.Nov 18, 2025
Nov 18, 2025Clarification sought from Narayana Hrudayalaya LtdNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year
Ended September 30 2025Nov 14, 2025
Nov 14, 2025Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Nov 11, 2025Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025Nov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Investor PresentationOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Oct 31, 2025Investor Presentation On The Acquisition Of UK-Based Practice Plus Group Hospitals LimitedOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-AcquisitionOct 30, 2025
Oct 30, 2025Incorporation Of Wholly-Owned Overseas Step-Down SubsidiaryOct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Sep 16, 2025Announcement Under Regulation 30 - AcquisitionSep 13, 2025
Sep 13, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 21, 2025
Aug 21, 2025Letter To Shareholders- Weblink Of 25Th AGM Notice And Annual Report For FY 2024-25Aug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2025
Aug 07, 2025Regulation 53 (1) Annual Report.Aug 07, 2025
Aug 07, 2025Reg. 34 (1) Annual Report.Aug 07, 2025
Aug 07, 2025Notice Of The 25Th Annual General Meeting (AGM) Of The Company For F.Y. 2024-25Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 03, 2025
Aug 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Aug 01, 2025Recommendation By The Board For The Issuance Of Non-Convertible Securities.Aug 01, 2025
Aug 01, 2025Mutual Fund Holdings
Parag Parikh Flexi Cap Fund Direct-Growth 
Axis Small Cap Fund Direct-Growth 
Nippon India Small Cap Fund Direct- Growth 
Mirae Asset Midcap Fund Direct - Growth 
DSP Small Cap Direct Plan-Growth 
Bandhan Small Cap Fund Direct-Growth 
Sundaram Business Cycle Fund Direct - Growth 
Taurus Flexi Cap Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth 
Capitalmind Flexi Cap Fund Direct - Growth 
UTI Multi Asset Allocation Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 52.81
ATR(14)
Less Volatile 62.59
STOCH(9,6)
Oversold 18.23
STOCH RSI(14)
Oversold 19.57
MACD(12,26)
Bearish -7.93
ADX(14)
Strong Trend 26.90
UO(9)
Bearish 36.42
ROC(12)
Downtrend And Accelerating -3.73
WillR(14)
Oversold -86.34
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years,
1 days)
Chairperson NameDEVI PRASAD SHETTY
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
